Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Emmessar Biotech and Nutrition Ltd (EMME)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.29 +2.01    +4.99%
- Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE634B01016 
S/N:  EMMESSA
  • Volume: 15,812
  • Bid/Ask: 42.29 / 42.29
  • Day's Range: 38.90 - 42.29
Emmessar Biotech and Nutrition 42.29 +2.01 +4.99%

Emmessar Biotech and Nutrition Ltd Company Profile

 
Get an in-depth profile of Emmessar Biotech and Nutrition Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Emmessar Biotech & Nutrition Limited, a healthcare company, engages in the manufacture and marketing of healthcare and nutritional products in India and internationally. It offers bone care powder; general health products, including Biosulf and MSM powder, cough syrup, and gel for the treatment of piles, varicose veins, and related secondary infections, as well as capsules under Diabeteze, Frejomus, Gud Heart, Gud Health, Releef, Sepecer, and Tire Not names; muscle care products, such as Muscle Flex capsules and gel; and sexual health products comprising ElectriQ capsules and gel for men and women. The company also offers skin care products that include cream under Cute-N-Comely, Magicream, Skin Glow, and Glide Shaving names; skin cure products, which comprise lotion, acne gel, cream under Bandruff, CalmCream, and CalmCream RESQ names; and capsules and ointment for eczema problem, fungi rid capsules and cream, psoriasis cream, and skin syrup. In addition, it offers pain relief, which include support joint powder and vedarin balm for osteoarthritis, joint pains, lockjaw, frozen shoulder, backache, headache, stiff neck, muscular aches, thigh muscle ache, and calf muscle ache. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Contact Information

Address 29, Kamer Building 4th Floor
38, Cawasji Patel Street Fort Mumbai,400001
India
Phone 91 22 3566 1373
Fax -

Top Executives

Name Age Since Title
Jeyavel Balaiah Nadar 62 2019 CFO, Executive Director & Internal Auditor
Mathurakavi Srinivasa Raghavan Ayyangar 75 1992 Founder, CEO, MD & Executive Chairman
Anuradha Srinivasa Raghavan 47 2013 Non-Executive Director
Sarada Srinivasa Raghavan - 2013 Non-Executive Director
Anantharama Sethumani Subramanian 58 2020 Independent Director
Milind Sitaram Desai 61 2022 Independent Director
Rajalakshmi Srinivasa Raghavan 73 2022 Additional Non Executive Director
Dinesh Kumar Deora 55 2024 Additional Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EMME Comments

Write your thoughts about Emmessar Biotech and Nutrition Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email